Work Area: Transactions

Latest content

IPBC Global kicks off at a time when private equity money is pouring into the IP market

Delegates talk big ticket investments and speculate on Kathi Vidal’s USPTO Director confirmation hearing in the Senate

15 November 2021

New Huawei transaction with top US patent asserter revealed

Dozens of communications patents changing hands in latest monetisation move from Chinese telecoms giant

12 November 2021

A $650 million deal is the latest in a growing number of CRISPR IP transactions

Last week’s licensing agreement between Mammoth and Vertex shows how deal-making in the space is gathering momentum

05 November 2021

Mitsubishi Electric adds technology licensing to its monetisation push

Creation of an “open technology bank” for fee-based use comes as world’s third-biggest PCT filer also does more deals with NPEs

05 November 2021

Five major platforms adopt standardised patent identification format to reduce portfolio management costs

Cipher, Unified Patents, RPX, Aon and Google Patents come together for the public launch of SPIF

02 November 2021

Key takeaways from Merck’s landmark covid IP licensing deal with the Medicines Patent Pool

The agreement is the first granting non-exclusive and royalty free rights to sub-licensees of a covid therapeutic or vaccine

02 November 2021

Flexibility crucial to growing appeal of big money drug royalty transactions, says leading deal-maker

In the wake of the firm’s latest $250 million investment, Sagard Healthcare Royalty Partners’ Ali Alagheband gives the inside track on life sciences IP-backed revenue sales

01 November 2021

Nokia Technologies boosts revenues and profits in strong Q3 patent licensing performance

Royalties grow on the back of new deals and renewals; company also shares new details on legal fight with Oppo, which does not appear to have significantly dimmed income outlook

29 October 2021

Hub and spoke IP strategies are generating billions of dollars in biopharma

New Crinetics spin-off is more evidence of the growing influence of models designed to monetise non-core life sciences assets

22 October 2021

IBM delivers hundreds of patents to DoorDash in latest big startup transaction

More than 200 assets change hands in the aftermath of a similarly-sized sale to delivery service Instacart

21 October 2021

Get unlimited access to all IAM content